Dechert LLP announced today that it advised Onconova Therapeutics, Inc. in an initial public offering of 5,166,667 shares of its common stock. The offering was announced today at $15.00 per share, before underwriting discounts. All of the shares of common stock are being offered by Onconova. In addition, Onconova has granted the underwriters a 30-day option to purchase up to an additional 775,000 shares of common stock at the same price to cover over-allotments, if any. The shares are now trading on The NASDAQ Global Market under the ticker symbol “ONTX.” The offering is expected to close on July 30, 2013, subject to customary closing conditions.
Dechert’s team included James Marino David Rosenthal, Ella DeTrizio, Derick Kauffman, Anthony Lagreca, Milad Sedeh (corporate), Thomas Rayski (IP), and Stephen Skonieczny and Sarah Rubenfeld (Executive Compensation/Employee Benefits).
Read Onoconva’s full press release.
